SANUWAVE HEALTH INC (SNWV) Stock Fundamental Analysis

NASDAQ:SNWV • US80303D3052

24.89 USD
+0.45 (+1.84%)
Last: Feb 13, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

SNWV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SNWV have multiple concerns. SNWV shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • SNWV had negative earnings in the past year.
  • SNWV had a positive operating cash flow in the past year.
  • In the past 5 years SNWV always reported negative net income.
  • In the past 5 years SNWV reported 4 times negative operating cash flow.
SNWV Yearly Net Income VS EBIT VS OCF VS FCFSNWV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • SNWV has a Return On Assets of -19.79%. This is comparable to the rest of the industry: SNWV outperforms 53.76% of its industry peers.
  • The Return On Invested Capital of SNWV (33.79%) is better than 99.46% of its industry peers.
Industry RankSector Rank
ROA -19.79%
ROE N/A
ROIC 33.79%
ROA(3y)-90.36%
ROA(5y)-110.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNWV Yearly ROA, ROE, ROICSNWV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

  • SNWV has a better Operating Margin (16.60%) than 86.56% of its industry peers.
  • SNWV has a better Gross Margin (78.26%) than 91.40% of its industry peers.
  • SNWV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.6%
PM (TTM) N/A
GM 78.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.85%
GM growth 5Y9.58%
SNWV Yearly Profit, Operating, Gross MarginsSNWV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • SNWV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, SNWV has more shares outstanding
  • SNWV has more shares outstanding than it did 5 years ago.
  • SNWV has a better debt/assets ratio than last year.
SNWV Yearly Shares OutstandingSNWV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SNWV Yearly Total Debt VS Total AssetsSNWV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • SNWV has an Altman-Z score of -4.50. This is a bad value and indicates that SNWV is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of SNWV (-4.50) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.5
ROIC/WACC3.21
WACC10.51%
SNWV Yearly LT Debt VS Equity VS FCFSNWV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that SNWV should not have too much problems paying its short term obligations.
  • SNWV has a worse Current ratio (1.16) than 82.26% of its industry peers.
  • SNWV has a Quick Ratio of 1.16. This is a bad value and indicates that SNWV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SNWV has a worse Quick ratio (0.81) than 81.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.81
SNWV Yearly Current Assets VS Current LiabilitesSNWV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • SNWV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -830.50%.
  • Looking at the last year, SNWV shows a very strong growth in Revenue. The Revenue has grown by 40.89%.
  • The Revenue has been growing by 99.64% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-830.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%117.4%
Revenue 1Y (TTM)40.89%
Revenue growth 3Y35.87%
Revenue growth 5Y99.64%
Sales Q2Q%22.34%

3.2 Future

  • The Earnings Per Share is expected to grow by 31.48% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, SNWV will show a very strong growth in Revenue. The Revenue will grow by 33.94% on average per year.
EPS Next Y106.17%
EPS Next 2Y46.14%
EPS Next 3Y31.48%
EPS Next 5YN/A
Revenue Next Year38.08%
Revenue Next 2Y34.58%
Revenue Next 3Y33.94%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SNWV Yearly Revenue VS EstimatesSNWV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SNWV Yearly EPS VS EstimatesSNWV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2025 2026 2027 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SNWV. In the last year negative earnings were reported.
  • SNWV is valuated quite expensively with a Price/Forward Earnings ratio of 26.10.
  • Based on the Price/Forward Earnings ratio, SNWV is valued a bit cheaper than the industry average as 74.19% of the companies are valued more expensively.
  • SNWV is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.96, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 26.1
SNWV Price Earnings VS Forward Price EarningsSNWV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • 70.97% of the companies in the same industry are more expensive than SNWV, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.3
SNWV Per share dataSNWV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • SNWV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as SNWV's earnings are expected to grow with 31.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.14%
EPS Next 3Y31.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SNWV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SANUWAVE HEALTH INC

NASDAQ:SNWV (2/13/2026, 8:00:02 PM)

24.89

+0.45 (+1.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)03-19
Inst Owners50.42%
Inst Owner Change1.23%
Ins Owners1.33%
Ins Owner Change-0.5%
Market Cap213.56M
Revenue(TTM)41.28M
Net Income(TTM)-7.04M
Analysts82.5
Price Target55.08 (121.29%)
Short Float %5.49%
Short Ratio7.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)42.63%
Min EPS beat(2)-26.01%
Max EPS beat(2)111.27%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)30.77%
EPS NQ rev (3m)-14.79%
EPS NY rev (1m)-46.2%
EPS NY rev (3m)872.73%
Revenue NQ rev (1m)-0.75%
Revenue NQ rev (3m)-1.87%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.1
P/S 5.17
P/FCF N/A
P/OCF 164.53
P/B N/A
P/tB N/A
EV/EBITDA 28.3
EPS(TTM)-0.93
EYN/A
EPS(NY)0.95
Fwd EY3.83%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.15
OCFY0.61%
SpS4.81
BVpS-0.34
TBVpS-1.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.79%
ROE N/A
ROCE 42.77%
ROIC 33.79%
ROICexc 84.32%
ROICexgc N/A
OM 16.6%
PM (TTM) N/A
GM 78.26%
FCFM N/A
ROA(3y)-90.36%
ROA(5y)-110.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.85%
GM growth 5Y9.58%
F-Score4
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 2.25
Cap/Depr 199.62%
Cap/Sales 5.04%
Interest Coverage 1.55
Cash Conversion 16.44%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.81
Altman-Z -4.5
F-Score4
WACC10.51%
ROIC/WACC3.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-830.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%117.4%
EPS Next Y106.17%
EPS Next 2Y46.14%
EPS Next 3Y31.48%
EPS Next 5YN/A
Revenue 1Y (TTM)40.89%
Revenue growth 3Y35.87%
Revenue growth 5Y99.64%
Sales Q2Q%22.34%
Revenue Next Year38.08%
Revenue Next 2Y34.58%
Revenue Next 3Y33.94%
Revenue Next 5YN/A
EBIT growth 1Y74.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year150.43%
EBIT Next 3Y67.94%
EBIT Next 5YN/A
FCF growth 1Y89.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.91%
OCF growth 3YN/A
OCF growth 5YN/A

SANUWAVE HEALTH INC / SNWV FAQ

Can you provide the ChartMill fundamental rating for SANUWAVE HEALTH INC?

ChartMill assigns a fundamental rating of 3 / 10 to SNWV.


Can you provide the valuation status for SANUWAVE HEALTH INC?

ChartMill assigns a valuation rating of 3 / 10 to SANUWAVE HEALTH INC (SNWV). This can be considered as Overvalued.


What is the profitability of SNWV stock?

SANUWAVE HEALTH INC (SNWV) has a profitability rating of 3 / 10.


What is the expected EPS growth for SANUWAVE HEALTH INC (SNWV) stock?

The Earnings per Share (EPS) of SANUWAVE HEALTH INC (SNWV) is expected to grow by 106.17% in the next year.